DE3323462A1 - Cephalosporin-antibiotika - Google Patents

Cephalosporin-antibiotika

Info

Publication number
DE3323462A1
DE3323462A1 DE19833323462 DE3323462A DE3323462A1 DE 3323462 A1 DE3323462 A1 DE 3323462A1 DE 19833323462 DE19833323462 DE 19833323462 DE 3323462 A DE3323462 A DE 3323462A DE 3323462 A1 DE3323462 A1 DE 3323462A1
Authority
DE
Germany
Prior art keywords
compound
group
acid
formula
toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19833323462
Other languages
German (de)
English (en)
Inventor
Brian Edgar Greenford Middlesex Looker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE3323462A1 publication Critical patent/DE3323462A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
DE19833323462 1982-06-30 1983-06-29 Cephalosporin-antibiotika Withdrawn DE3323462A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8218874 1982-06-30
GB8222236 1982-08-02

Publications (1)

Publication Number Publication Date
DE3323462A1 true DE3323462A1 (de) 1984-01-12

Family

ID=26283232

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833323462 Withdrawn DE3323462A1 (de) 1982-06-30 1983-06-29 Cephalosporin-antibiotika

Country Status (16)

Country Link
US (1) US4560683A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0098161A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU1638183A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3323462A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK299083A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8500957A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI832385L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2529555A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2123414B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR77529B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1212876B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU84887A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8302309A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO832376L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT76960B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE8303727L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3322783A1 (de) * 1982-06-29 1984-02-09 Astra Läkemedel AB, 15185 Södertälje Verfahren zur herstellung von 1-aethoxycarbonyloxyaethylestern von penicillinen, 6-aminopenicillansaeure oder cephalosporinen
DE3348300C2 (de) * 1982-06-29 1994-04-21 Astra Laekemedel Ab Verwendung von alpha-Bromdiethylcarbonat

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148004A3 (en) * 1983-12-30 1986-04-23 Glaxo Group Limited Cephalosporin antibiotics
GB8504072D0 (en) * 1985-02-18 1985-03-20 Fujisawa Pharmaceutical Co Cephem compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US3966717A (en) * 1971-05-14 1976-06-29 Glaxo Laboratories Limited 7-β-Acylamido-3-carbamoyloxymethylceph-3-em-4-carboxylic acids and salts thereof
US4162360A (en) * 1973-12-21 1979-07-24 Glaxo Laboratories Limited 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
US3946002A (en) * 1974-07-11 1976-03-23 Lilly Industries Limited Process for preparing cephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
FR2361895A1 (fr) * 1976-08-20 1978-03-17 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
GB2029824B (en) * 1978-05-26 1983-02-16 Glaxo Group Ltd 7-oximino-2-amino-4-thiazolyl acetamido cephens
DE3069560D1 (en) * 1979-09-03 1984-12-06 Fujisawa Pharmaceutical Co Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
EP0037797A3 (de) * 1980-03-11 1981-12-16 Ciba-Geigy Ag Cephalosporinverbindungen, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3322783A1 (de) * 1982-06-29 1984-02-09 Astra Läkemedel AB, 15185 Södertälje Verfahren zur herstellung von 1-aethoxycarbonyloxyaethylestern von penicillinen, 6-aminopenicillansaeure oder cephalosporinen
DE3348300C2 (de) * 1982-06-29 1994-04-21 Astra Laekemedel Ab Verwendung von alpha-Bromdiethylcarbonat

Also Published As

Publication number Publication date
IT1212876B (it) 1989-11-30
FR2529555A1 (fr) 1984-01-06
US4560683A (en) 1985-12-24
FI832385A7 (fi) 1983-12-31
ES523682A0 (es) 1984-11-01
SE8303727D0 (sv) 1983-06-29
SE8303727L (sv) 1984-02-03
GB8317617D0 (en) 1983-08-03
IT8348598A0 (it) 1983-06-29
EP0098161A3 (en) 1985-04-24
GR77529B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-24
AU1638183A (en) 1984-01-05
PT76960A (en) 1983-07-01
EP0098161A2 (en) 1984-01-11
DK299083D0 (da) 1983-06-29
DK299083A (da) 1983-12-31
GB2123414A (en) 1984-02-01
FI832385A0 (fi) 1983-06-29
GB2123414B (en) 1985-12-04
LU84887A1 (fr) 1984-03-07
FI832385L (fi) 1983-12-31
NL8302309A (nl) 1984-01-16
ES8500957A1 (es) 1984-11-01
PT76960B (en) 1986-01-24
AU1637983A (en) 1984-01-05
NO832376L (no) 1984-01-02

Similar Documents

Publication Publication Date Title
AT370420B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
DE2439880C3 (de) (6R, 7R)-3-Carbamoyloxymethyl-7- [2-(fur-2-yl)-2methoxyiminoacetamido] -ceph-S-em^carbonsäure und Verfahren zur ihrer Herstellung
AT369749B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
DE2744135A1 (de) Cephalosporinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH655118A5 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und antibakterielle mittel, die diese verbindungen enthalten.
CH647784A5 (de) Cephalosporinantibiotika.
DE2943427A1 (de) Cephalosporinverbindungen
CH649557A5 (de) Cephalosporinantibiotika.
DE3011038A1 (de) Cephalosporinantibiotika
DE3323462A1 (de) Cephalosporin-antibiotika
CH649298A5 (de) Cephalosporin-antibiotika.
DE2943437A1 (de) Cephalosporinverbindungen
AT391319B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
CH627758A5 (en) Process for the preparation of the syn isomer or a mixture of the syn isomer and anti isomer of 7beta-acylamidoceph-3-em-4-carboxylic acids with the antibiotic activity
DE3342317A1 (de) Cephalosporin-antibiotika
DE3323450A1 (de) Cephalosporin-antibiotika
AT375663B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT375662B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
DE2536337A1 (de) Cephalosporin-antibiotika
AT371126B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT371474B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT384613B (de) Verfahren zur herstellung von neuen cephalosporinderivaten
DE2921344A1 (de) Cephalosporinantibiotika
AT371476B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
CH649297A5 (en) Cephalosporin compounds, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee